Chunmeng Shi Selected Research

Antibodies

10/2011	A review of NIR dyes in cancer targeting and imaging.
1/2009	Beta2-microglobulin: emerging as a promising cancer therapeutic target.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunmeng Shi Research Topics

Disease

42	Neoplasms (Cancer) 03/2024 - 01/2008
14	Wounds and Injuries (Trauma) 02/2024 - 01/2003
9	Fibrosis (Cirrhosis) 09/2023 - 04/2015
6	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 01/2016
6	Neoplasm Metastasis (Metastasis) 10/2020 - 05/2010
5	Inflammation (Inflammations) 12/2023 - 01/2019
4	Ulcer 01/2023 - 01/2019
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 10/2020
3	Prostatic Neoplasms (Prostate Cancer) 01/2019 - 08/2008
2	Breast Neoplasms (Breast Cancer) 03/2024 - 12/2021
2	Urinary Bladder Neoplasms (Bladder Cancer) 10/2023 - 02/2023
2	Infections 10/2023 - 04/2023
2	Sepsis (Septicemia) 04/2023 - 11/2015
2	Disease Progression 01/2021 - 09/2020
2	Cicatrix (Scar) 01/2020 - 01/2019
2	Glaucoma 01/2020 - 01/2020
2	Carcinogenesis 08/2017 - 11/2016
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2010 - 11/2010
1	Ischemia 12/2023
1	Heart Failure 12/2023
1	Neuroinflammatory Diseases 01/2023
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Brain Injuries (Brain Injury) 01/2023
1	Cognitive Dysfunction 01/2023
1	Mucositis 01/2023
1	Melanoma (Melanoma, Malignant) 01/2023
1	Cystitis 01/2023
1	Urinary Bladder Diseases (Bladder Diseases) 12/2022
1	Hemorrhagic Cystitis 12/2022
1	Lung Injury 05/2022
1	Nausea 01/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Vomiting 01/2022
1	Diarrhea 01/2022
1	Triple Negative Breast Neoplasms 12/2021

Drug/Important Bio-Agent (IBA)

17	Coloring Agents (Dyes)IBA 01/2024 - 05/2010
14	2- (2- (2- chloro- 3- ((1,3- dihydro- 3,3- dimethyl- 1- propyl- 2H- indol- 2- ylidene)ethylidene)- 1- cyclohexen- 1- yl)ethenyl)- 3,3- dimethyl- 1- propylindoliumIBA 01/2024 - 09/2010
8	Therapeutic UsesIBA 04/2023 - 07/2004
7	Peptides (Polypeptides)IBA 01/2018 - 05/2010
6	CollagenIBA 02/2024 - 01/2003
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 10/2011
5	Fluorescent Dyes (Fluorescent Probes)IBA 10/2023 - 01/2008
5	Contrast MediaIBA 11/2017 - 03/2013
5	LigandsIBA 01/2016 - 08/2008
3	IodidesIBA 02/2023 - 09/2010
3	RNA (Ribonucleic Acid)IBA 01/2023 - 08/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2009
3	Organic Anion TransportersIBA 01/2018 - 09/2010
3	AnionsIBA 11/2017 - 05/2010
2	Hyaluronic Acid (Hyaluronan)IBA 10/2023 - 12/2022
2	InflammasomesIBA 10/2023 - 01/2023
2	Succinate Dehydrogenase (Fumarate Reductase)IBA 09/2023 - 10/2021
2	Bleomycin (Blenoxane)FDA LinkGeneric 09/2023 - 10/2021
2	Oxygen (Dioxygen)IBA 02/2023 - 09/2020
2	Radiation-Protective Agents (Radiation Protectants)IBA 01/2023 - 01/2022
2	HydrogelsIBA 12/2022 - 08/2019
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2022 - 03/2013
2	Human Serum Albumin FDA LinkGeneric 01/2022 - 11/2017
2	AlbuminsIBA 01/2022 - 11/2017
2	Metformin (Glucophage)FDA LinkGeneric 01/2020 - 01/2020
2	AntioxidantsIBA 01/2020 - 01/2019
2	AntigensIBA 01/2019 - 08/2009
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 11/2017 - 07/2016
2	MicroRNAs (MicroRNA)IBA 11/2015 - 12/2012
2	AntibodiesIBA 10/2011 - 01/2009
2	Sulfobromophthalein (Sulfobromophthalein Sodium)IBA 09/2010 - 05/2010
2	heptamethine cyanine dyeIBA 09/2010 - 05/2010
2	Proliferating Cell Nuclear Antigen (PCNA)IBA 06/2004 - 10/2003
2	Nuclear Antigens (Extractable Nuclear Antigens)IBA 06/2004 - 10/2003
1	4- t- butylphenyl- N- (4- imidazol- 1- ylphenyl)sulfonamideIBA 03/2024
1	Hormones (Hormone)IBA 03/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	Monoclonal AntibodiesIBA 01/2024
1	Polypropylenes (Polypropylene)IBA 12/2023
1	Biocompatible Materials (Biomaterials)IBA 12/2023
1	polydopamineIBA 10/2023
1	Mitochondrial DNA (mtDNA)IBA 10/2023
1	HMGB1 Protein (HMG1)IBA 01/2023
1	Tight Junction ProteinsIBA 01/2023
1	Conditioned Culture MediaIBA 01/2023
1	Interleukin-18 (Interleukin 18)IBA 01/2023
1	Transcription Factors (Transcription Factor)IBA 05/2022
1	Fibronectins (Fibronectin)IBA 05/2022
1	Serum AlbuminIBA 01/2022
1	Nuclear Proteins (Protein, Nuclear)IBA 12/2021
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 12/2021
1	Succinic Acid (Succinate)IBA 10/2021
1	artemisinin (artemisinine)IBA 01/2021

Therapy/Procedure

22	Therapeutics 10/2023 - 01/2006
11	Radiotherapy 02/2024 - 04/2016
8	Precision Medicine 07/2018 - 02/2012
5	Transplantation 01/2023 - 01/2003
4	Drug Therapy (Chemotherapy) 10/2023 - 10/2016
4	Quantum Dots (Quantum Dot) 12/2010 - 01/2008
2	Immunotherapy 01/2024 - 01/2019
2	Filtering Surgery 01/2020 - 01/2020
2	Phototherapy (Light Therapy) 01/2019 - 07/2016
2	Intravenous Injections 07/2016 - 08/2009
2	Photochemotherapy (Photodynamic Therapy) 07/2016 - 03/2012
1	Intravesical Administration 10/2023